E Fund Management Co., Ltd. Immunity Bio, Inc. Transaction History
E Fund Management Co., Ltd.
- $2.06 Billion
- Q2 2025
A detailed history of E Fund Management Co., Ltd. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 28,108 shares of IBRX stock, worth $58,464. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,108
Previous 30,331
7.33%
Holding current value
$58,464
Previous $91,000
18.68%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IBRX
# of Institutions
296Shares Held
137MCall Options Held
2.59MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA27.7MShares$57.5 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY12.8MShares$26.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.3MShares$23.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$14.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $833M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...